DGAP-News: Idaho Technology Launches FilmArray(R) Respiratory Panel at European Congress of Clinical Microbiology and Infectious Diseases

Idaho Technology Inc.

02.04.2012 09:00
—————————————————————————

Establishes Distribution Network to Market in Europe

SALT LAKE CITY, 2012-04-02 09:00 CEST (GLOBE NEWSWIRE) —
Idaho Technology, Inc., a privately held biotechnology and clinical diagnostics
company dedicated to providing the world–s fastest, highest-quality instruments
for pathogen identification and DNA analysis, today announced the European
launch of its FilmArray Respiratory Panel (FilmArray RP), a multiplex clinical
diagnostic product that simultaneously detects 21 respiratory pathogens in
about one hour. FilmArray RP is Idaho Technology–s first clinical diagnostic
test designed to run on the Company–s user-friendly FilmArray system. The
FilmArray RP received FDA 510(k) clearance last year for a panel of 15 analytes
and recently achieved CE in vitro diagnostic (IVD) registration in the E.U. for
a panel of 21 analytes.

The Company also announced that it is partnering with the DiaMondiaL family of
distributors in strategic territories throughout Europe. Each of these partners
is well recognized as a leading supplier of laboratory instruments and testing
services, and will now add FilmArray RP to their product offerings.

The product is being showcased at the European Congress of Clinical
Microbiology and Infectious Diseases (ECCMID), held March 31 – April 3, 2012,
at ExCeL London, London, UK (Booth 567).

–Launching FilmArray RP in Europe represents a significant milestone for our
clinical diagnostics business,– said Kirk Ririe, Chief Executive Officer of
Idaho Technology. –Along with our esteemed distribution partners, we are
pleased to offer our user-friendly multiplex pathogen detection system to the
broad community of clinical laboratory professionals. Our FilmArray system is
capable of testing for a comprehensive panel of viral and bacterial pathogens
in about one hour, while offering the user only two minutes of hands-on time,
with no precise measuring or pipetting required. We believe this represents a
significant advancement in the field of infectious disease detection, with the
potential to improve the testing capacity of hospital clinical laboratories
worldwide.–

Since launching in the U.S., FilmArray RP has experienced rapid adoption by the
clinical laboratory community. In January 2012, Idaho Technology filed a
submission with the FDA to clear five additional respiratory pathogens in an
expanded panel for use on the FilmArray system. The Company expects to receive
FDA clearance for the expanded panel in the second quarter of 2012. Idaho
Technology is continuing to develop a broader test menu for its FilmArray
system, including a blood culture ID panel, gastrointestinal panel, and an STI
panel.

About FilmArray RP

FilmArray RP is Idaho Technology–s first clinical diagnostic test designed to
run on the Company–s novel FilmArray system, which represents a significant
advancement in user-friendliness and multiplex infectious disease testing
capability for hospital clinical labs. FilmArray RP rapidly detects nucleic
acids in nasopharyngeal swabs obtained from individuals suspected of
respiratory tract infections. Requiring only two minutes of hands-on time,
FilmArray RP has about a 1-hour turnaround time, and simultaneously tests for
the following panel of respiratory pathogens: Adenovirus, Bocavirus,
Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, Human
Metapneumovirus, Influenza A, Influenza A subtype H1, Influenza A subtype H3,
Influenza A subtype H1 2009, Influenza B, Parainfluenza virus 1, Parainfluenza
virus 2, Parainfluenza virus 3, Parainfluenza virus 4, Rhinovirus/Enterovirus,
Respiratory Syncytial Virus, Bordetella pertussis, Chlamydophila pneumoniae,
and Mycoplasma pneumonia. FilmArray RP has received FDA-clearance for a panel
of 15 of these targets and CE IVD registration for a panel of all 21 targets.
The FilmArray is available for use by hospital and clinical laboratory
professionals in the United States and Europe.

About Idaho Technology Inc.

Idaho Technology Inc. is a privately held biotechnology and clinical
diagnostics company based in Salt Lake City, Utah. Founded in 1990, the company
currently holds over 70 patents related to polymerase chain reaction (PCR),
including rapid PCR cycling. The company has used its extensive patent
portfolio to successfully market nearly 200 products to the clinical, research
and military markets and works closely with various governmental agencies
including United States Department of Health and Human Services, the Department
of Defense and the Food and Drug Administration. Among others, researchers,
medical technicians, law enforcement officers, and soldiers in the field use
company devices to detect or study disease-causing organisms. For further
information, please visit www.idahotech.com.

CONTACT: Wade Stevenson
800-735-6544
wade.stevenson@idahotech.com
News Source: NASDAQ OMX

02.04.2012 Dissemination of a Corporate News, transmitted by DGAP –
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP–s Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

—————————————————————————

Language: English
Company: Idaho Technology Inc.

United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US9901962301
WKN:

End of Announcement DGAP News-Service

—————————————————————————

  idaho-technology-launches-filmarray-r-respiratory-panel-at-european-congress-of-clinical-microbiology-and-infectious-diseases